PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma-Reference-Cited by-同舟云学术

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma

Published:2018-01 Issue: Volume:88 Page:67-76
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Schaper-Gerhardt Katrin,Okoye Steven,Herbst Rudolf,Ulrich Jens,Terheyden Patrick,Pföhler Claudia,Utikal Jochen S.,Kreuter Alexander,Mohr Peter,Dippel Edgar,Satzger Imke,Sucker Antje,Schadendorf Dirk,Ugurel Selma,Gutzmer Ralf

Funder

BMS

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Developments in targeted therapy in melanoma;Amann;Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol,2016

2. Efficacy and safety of Nivolumab in patients with BRAF V600 mutant and BRAF wild-type advanced melanoma: a pooled analysis of 4 clinical trials;Larkin;JAMA Oncol,2015

3. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy;Taube;Clin Cancer Res,2014

4. The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600;Massi;Ann Oncol,2015

5. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma”;Pflugfelder;J Dtsch Dermatol Ges,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship;International Journal of Molecular Sciences;2024-01-04

2. The Evolution of the Sentinel Node Biopsy in Melanoma;Life;2023-02-10

3. PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells;Journal of Personalized Medicine;2023-01-27

4. Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis;Molecular Diagnosis & Therapy;2022-02-01

5. Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy;Biomedicines;2022-01-26